These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 33540528)

  • 21. Phage steering of antibiotic-resistance evolution in the bacterial pathogen,
    Gurney J; Pradier L; Griffin JS; Gougat-Barbera C; Chan BK; Turner PE; Kaltz O; Hochberg ME
    Evol Med Public Health; 2020; 2020(1):148-157. PubMed ID: 34254028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The potential of phage therapy in cystic fibrosis: Essential human-bacterial-phage interactions and delivery considerations for use in Pseudomonas aeruginosa-infected airways.
    Trend S; Fonceca AM; Ditcham WG; Kicic A; Cf A
    J Cyst Fibros; 2017 Nov; 16(6):663-670. PubMed ID: 28720345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design of Phage-Cocktail-Containing Hydrogel for the Treatment of
    Shafigh Kheljan F; Sheikhzadeh Hesari F; Aminifazl MS; Skurnik M; Goladze S; Zarrini G
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and impact on
    Forti F; Bertoli C; Cafora M; Gilardi S; Pistocchi A; Briani F
    Microbiol Spectr; 2023 Dec; 11(6):e0147723. PubMed ID: 37966242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of
    Burke KA; Urick CD; Mzhavia N; Nikolich MP; Filippov AA
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of expanded host range phage active on biofilms of multi-drug resistant
    Mapes AC; Trautner BW; Liao KS; Ramig RF
    Bacteriophage; 2016; 6(1):e1096995. PubMed ID: 27144083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Engineered Superinfective Pf Phage Prevents Dissemination of Pseudomonas aeruginosa in a Mouse Burn Model.
    Prokopczuk FI; Im H; Campos-Gomez J; Orihuela CJ; Martínez E
    mBio; 2023 Jun; 14(3):e0047223. PubMed ID: 37039641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and Evaluation of Bacteriophage Cocktail to Eradicate Biofilms Formed by an Extensively Drug-Resistant (XDR)
    Vashisth M; Jaglan AB; Yashveer S; Sharma P; Bardajatya P; Virmani N; Bera BC; Vaid RK; Anand T
    Viruses; 2023 Feb; 15(2):. PubMed ID: 36851640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pseudomonas aeruginosa adaptation to lungs of cystic fibrosis patients leads to lowered resistance to phage and protist enemies.
    Friman VP; Ghoul M; Molin S; Johansen HK; Buckling A
    PLoS One; 2013; 8(9):e75380. PubMed ID: 24069407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of a new
    Whiteley LE; Whiteley M
    Microbiol Spectr; 2024 Mar; 12(3):e0371923. PubMed ID: 38345389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of Lytic Phage Cocktails on
    Kifelew LG; Warner MS; Morales S; Thomas N; Gordon DL; Mitchell JG; Speck PG
    Viruses; 2020 May; 12(5):. PubMed ID: 32443619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients.
    Chang RYK; Das T; Manos J; Kutter E; Morales S; Chan HK
    AAPS J; 2019 Apr; 21(3):49. PubMed ID: 30949776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-adapting parasitic phages to a pathogen leads to increased pathogen clearance and lowered resistance evolution with Pseudomonas aeruginosa cystic fibrosis bacterial isolates.
    Friman VP; Soanes-Brown D; Sierocinski P; Molin S; Johansen HK; Merabishvili M; Pirnay JP; De Vos D; Buckling A
    J Evol Biol; 2016 Jan; 29(1):188-98. PubMed ID: 26476097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of a Primary Epithelial Cell Screening Tool to Investigate Phage Therapy in Cystic Fibrosis.
    Trend S; Chang BJ; O'Dea M; Stick SM; Kicic A; ; ;
    Front Pharmacol; 2018; 9():1330. PubMed ID: 30546305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phage therapy in lung infections caused by multidrug-resistant Pseudomonas aeruginosa - A literature review.
    Eiselt VA; Bereswill S; Heimesaat MM
    Eur J Microbiol Immunol (Bp); 2024 Feb; 14(1):1-12. PubMed ID: 38261031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomic characterization of lytic bacteriophages targeting genetically diverse
    Nordstrom HR; Evans DR; Finney AG; Westbrook KJ; Zamora PF; Hofstaedter CE; Yassin MH; Pradhan A; Iovleva A; Ernst RK; Bomberger JM; Shields RK; Doi Y; Van Tyne D
    iScience; 2022 Jun; 25(6):104372. PubMed ID: 35620437
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparative analysis of effectiveness for phage cocktail development against multiple Salmonella serovars and its biofilm control activity.
    Ribeiro JM; Pereira GN; Durli Junior I; Teixeira GM; Bertozzi MM; Verri WA; Kobayashi RKT; Nakazato G
    Sci Rep; 2023 Aug; 13(1):13054. PubMed ID: 37567926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Bacteriophages Show Activity against Selected Australian Clinical Strains of
    Namonyo S; Carvalho G; Guo J; Weynberg KD
    Microorganisms; 2022 Jan; 10(2):. PubMed ID: 35208664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterogenous Susceptibility to R-Pyocins in Populations of Pseudomonas aeruginosa Sourced from Cystic Fibrosis Lungs.
    Mei M; Thomas J; Diggle SP
    mBio; 2021 May; 12(3):. PubMed ID: 33947755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacteriophages as a potential substitute for antibiotics: A comprehensive review.
    Kushwaha SO; Sahu SK; Yadav VK; Rathod MC; Patel D; Sahoo DK; Patel A
    Cell Biochem Funct; 2024 Apr; 42(3):e4022. PubMed ID: 38655589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.